Neoplastic disease and deletion 22q11.2: a multicentric study and report of two cases

Pediatr Pathol Mol Med. 2003 Jul-Aug;22(4):323-41. doi: 10.1080/pdp.22.4.323.341.

Abstract

Deletion 22q11.2 is a chromosomal abnormality detected in young patients with clinical manifestations of the DiGeorge/velocardiofacial syndrome. Conotruncal heart defects are also associated with del22q11.2. An association of these cardiac malformations with neoplasias has been observed. Our series includes two cases of malignancies, a hepatoblastoma and a renal-cell carcinoma, arising in children with complex cardiac malformations. The aim of the study was to determine if the deletion at 22q11.2 was present and could be responsible for both pathological processes. Del22q11.2 was identified in both cases. Comparative genomic hybridization revealed terminal gains on chromosomes 1q and Xq and terminal loss on 1p in the hepatoblastoma, and gains in 1p, 12q, 16p, 20q, 22q, and whole chromosome 19 and loss of Xq in the renal-cell carcinoma. Our results confirm a common genetic basis for cardiac malformations, and del22q11.2 presents a risk factor for the development of pediatric tumours.

Publication types

  • Case Reports
  • Comparative Study
  • Multicenter Study

MeSH terms

  • Carcinoma, Renal Cell / genetics
  • Carcinoma, Renal Cell / pathology
  • Child
  • Chromosome Deletion*
  • Chromosomes, Human, Pair 22*
  • DiGeorge Syndrome / diagnosis
  • DiGeorge Syndrome / genetics
  • Fatal Outcome
  • Female
  • Heart Defects, Congenital / genetics
  • Heart Defects, Congenital / pathology
  • Hepatoblastoma / genetics
  • Hepatoblastoma / pathology
  • Humans
  • In Situ Hybridization, Fluorescence
  • Infant, Newborn
  • Male
  • Microsatellite Repeats
  • Neoplasms / genetics*
  • Neoplasms / pathology*
  • Nucleic Acid Hybridization
  • Polymorphism, Genetic